ScholarIQanswers from OpenAlex

Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans

PaperCitations, authors & open-access status

Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans have?

ScholarIQcitation count

Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans has 38 citations in the OpenAlex counts ScholarIQ stores.

When was Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans published?

ScholarIQyear

Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans has 2012 year in the ScholarIQ index.

What is the open-access status of Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans?

ScholarIQoa status

Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans has closed oa status in the ScholarIQ index.

What is the DOI of Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans?

ScholarIQdoi

The DOI for Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans is on the source record.

What is the PMID of Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans?

ScholarIQpmid

The PMID for Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans is on the source record.

What is the OpenAlex record for Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans?

ScholarIQopenalex

The OpenAlex for Pharmacokinetics and metabolism of [<sup>14</sup>C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial